The global disposable medical supplies market, valued at $658 billion in 2026**, is witnessing a significant shift in export dynamics, with **China solidifying its position as the world’s leading exporter** while the Belt & Road Initiative (BRI) and ASEAN regions emerge as key growth drivers. In Q1 2026, China’s medical device exports reached **$14.81 billion, with disposable supplies accounting for 50.5% ($7.48 billion) of the total, representing a 5.97% year-on-year increase.
China’s export portfolio is dominated by syringes, gloves, wound dressings, and catheters, with syringe exports alone rising 14.5% YoY. The BRI countries and ASEAN have become the fastest-growing markets: exports to Vietnam, Singapore, and Malaysia increased by 12%–18% in 2025/26, while Russia and Central Asia show strong demand for basic disposable supplies. Meanwhile, China’s share of the global syringe market has reached 51%, outpacing India (18%) and Southeast Asia (12%).
Industry analysts attribute China’s competitiveness to mature supply chains, cost-effectiveness, and strict quality control. Over 85% of Chinese disposable medical supply manufacturers have obtained CE or FDA certifications, meeting international standards. As global healthcare spending rises and medical infrastructure expands in emerging markets, China’s disposable medical supplies exports are projected to grow at a 7%–9% CAGR through 2030.
